Literature DB >> 21248787

The role of G protein-coupled receptors in the pathology of Alzheimer's disease.

Amantha Thathiah1, Bart De Strooper.   

Abstract

G protein-coupled receptors (GPCRs) are involved in numerous key neurotransmitter systems in the brain that are disrupted in Alzheimer's disease (AD). GPCRs also directly influence the amyloid cascade through modulation of the α-, β- and γ-secretases, proteolysis of the amyloid precursor protein (APP), and regulation of amyloid-β degradation. Additionally, amyloid-β has been shown to perturb GPCR function. Emerging insights into the mechanistic link between GPCRs and AD highlight the potential of this class of receptors as a therapeutic target for AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248787     DOI: 10.1038/nrn2977

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  196 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors.

Authors:  F Ferraguti; B Baldani-Guerra; M Corsi; S Nakanishi; C Corti
Journal:  Eur J Neurosci       Date:  1999-06       Impact factor: 3.386

3.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

4.  Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

Authors:  Takashi Saito; Nobuhisa Iwata; Satoshi Tsubuki; Yoshie Takaki; Jiro Takano; Shu-Ming Huang; Takahiro Suemoto; Makoto Higuchi; Takaomi C Saido
Journal:  Nat Med       Date:  2005-03-20       Impact factor: 53.440

5.  Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells.

Authors:  E Sadot; D Gurwitz; J Barg; L Behar; I Ginzburg; A Fisher
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

6.  Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.

Authors:  E B De Souza; P J Whitehouse; M J Kuhar; D L Price; W W Vale
Journal:  Nature       Date:  1986 Feb 13-19       Impact factor: 49.962

7.  Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer's disease.

Authors:  Pancham Bakshi; Elaina Margenthaler; Jon Reed; Fiona Crawford; Michael Mullan
Journal:  Cytokine       Date:  2010-11-16       Impact factor: 3.861

Review 8.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.

Authors:  Jürgen Wess; Richard M Eglen; Dinesh Gautam
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

9.  Activation of protein kinase C inhibits cellular production of the amyloid beta-protein.

Authors:  A Y Hung; C Haass; R M Nitsch; W Q Qiu; M Citron; R J Wurtman; J H Growdon; D J Selkoe
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

10.  A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

Authors:  M Ruat; E Traiffort; J M Arrang; J Tardivel-Lacombe; J Diaz; R Leurs; J C Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

View more
  101 in total

1.  Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Keely M Murphy; Liping Meng; Janitza Montalvo-Ortiz; Ziling Zeng; Benedict J Kolber; Shanshan Zhang; Louis J Muglia; John G Csernansky
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

Review 3.  Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies.

Authors:  George M Martin
Journal:  Mech Ageing Dev       Date:  2011-09-22       Impact factor: 5.432

4.  Novel GαS-protein signaling associated with membrane-tethered amyloid precursor protein intracellular domain.

Authors:  Carole Deyts; Kulandaivelu S Vetrivel; Shibandri Das; Yumiko M Shepherd; Denis J Dupré; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

5.  Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky
Journal:  Neuroscientist       Date:  2015-05-22       Impact factor: 7.519

6.  APP-Mediated Signaling Prevents Memory Decline in Alzheimer's Disease Mouse Model.

Authors:  Carole Deyts; Mary Clutter; Nicholas Pierce; Paramita Chakrabarty; Thomas B Ladd; Anna Goddi; Awilda M Rosario; Pedro Cruz; Kulandaivelu Vetrivel; Steven L Wagner; Gopal Thinakaran; Todd E Golde; Angèle T Parent
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

Review 7.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

Review 8.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

9.  Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay.

Authors:  Andrew J Storaska; Jian P Mei; Meng Wu; Min Li; Susan M Wade; Levi L Blazer; Benita Sjögren; Corey R Hopkins; Craig W Lindsley; Zhihong Lin; Joseph J Babcock; Owen B McManus; Richard R Neubig
Journal:  Cell Signal       Date:  2013-09-14       Impact factor: 4.315

10.  Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia.

Authors:  Yuanchao Ye; Zhizeng Sun; Ang Guo; Long-Sheng Song; Justin L Grobe; Songhai Chen
Journal:  Cell Signal       Date:  2014-08-02       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.